151 related articles for article (PubMed ID: 11438667)
1. Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.
Weinstein M; Monga SP; Liu Y; Brodie SG; Tang Y; Li C; Mishra L; Deng CX
Mol Cell Biol; 2001 Aug; 21(15):5122-31. PubMed ID: 11438667
[TBL] [Abstract][Full Text] [Related]
2. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
Alvarez J; Serra R
Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.
Ito Y; Sarkar P; Mi Q; Wu N; Bringas P; Liu Y; Reddy S; Maxson R; Deng C; Chai Y
Dev Biol; 2001 Aug; 236(1):181-94. PubMed ID: 11456453
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
5. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
6. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
8. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ
Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346
[TBL] [Abstract][Full Text] [Related]
9. Long-term expansion of human functional epidermal precursor cells: promotion of extensive amplification by low TGF-beta1 concentrations.
Fortunel NO; Hatzfeld JA; Rosemary PA; Ferraris C; Monier MN; Haydont V; Longuet J; Brethon B; Lim B; Castiel I; Schmidt R; Hatzfeld A
J Cell Sci; 2003 Oct; 116(Pt 19):4043-52. PubMed ID: 12953061
[TBL] [Abstract][Full Text] [Related]
10. Intracellular dynamics of Smad-mediated TGFbeta signaling.
Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
[TBL] [Abstract][Full Text] [Related]
11. Signaling "cross-talk" between TGF-beta1 and ECM signals in chondrocytic cells.
Schneiderbauer MM; Dutton CM; Scully SP
Cell Signal; 2004 Oct; 16(10):1133-40. PubMed ID: 15240008
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion.
Cui XM; Chai Y; Chen J; Yamamoto T; Ito Y; Bringas P; Shuler CF
Dev Dyn; 2003 Jul; 227(3):387-94. PubMed ID: 12815624
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
14. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
[TBL] [Abstract][Full Text] [Related]
15. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
16. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
[TBL] [Abstract][Full Text] [Related]
17. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
18. [The roles of Smad 2/3 in transforming growth factor-beta 1 signaling in human dental pulp cells].
Bao LY; Niu ZY; Wang P
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):39-42. PubMed ID: 12760775
[TBL] [Abstract][Full Text] [Related]
19. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta.
Yang X; Letterio JJ; Lechleider RJ; Chen L; Hayman R; Gu H; Roberts AB; Deng C
EMBO J; 1999 Mar; 18(5):1280-91. PubMed ID: 10064594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
